Company news
Exicure, Inc. news in 2022
Exicure, Inc.'s news releases, calls and decks from 2022, newest first.
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
December 13, 2022
Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 13, 2022
Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives
September 25, 2022
Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference
August 31, 2022
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
August 14, 2022
Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 19, 2022
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
June 28, 2022
Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders
May 26, 2022
Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
May 16, 2022
Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress
May 15, 2022
Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium
May 9, 2022
Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference
May 8, 2022
Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress
March 24, 2022
Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
February 3, 2022
Decks in 2022
- Investor Presentation (January 2022)
Investor deck · 23 slides · Jan 5, 2022